← All trials
NCT01233843
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2009
- Primary completion
- Feb 1, 2016
- Completion date
- May 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 370
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Groupe Oncologie Radiotherapie Tete et CouLead sponsor
- Centre Georges Francois LeclercOverall official - principal investigator
- Centre Guillaume le Conquerant LE HAVRE FranceOverall official - principal investigator
- Hopital Bretagne Sud LORIENTOverall official - principal investigator
- Hopital Emile Muller MULHOUSE FranceOverall official - principal investigator
- Centre Saint Louis TOULON FranceOverall official - principal investigator
- Centre Etienne Dolet SAINT NAZAIRE FranceOverall official - principal investigator
- Institut Gustave RoussyOverall official - principal investigator
- RocheOverall official - principal investigator
- University of PoitiersOverall official - principal investigator
- University of Picardie Jules VerneOverall official - principal investigator
- Centre Hospitalier de Saint-BrieucOverall official - principal investigator
- University of LorraineStudy director
- Centre Jean BernardOverall official - principal investigator
- Centre Jean PerrinOverall official - principal investigator
- Institut de Cancerologie de l'Ouest Paul PapinOverall official - principal investigator
- University of BordeauxOverall official - principal investigator
- University of Caen-NormandieOverall official - principal investigator
- University of AngersOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.